Identification of novel subgroups of high-risk pediatric precursor B acute lymphoblastic leukemia, outcome correlations and diagnostic and therapeutic methods related to same
US8568974B2 · kind B2 · utility
0Cited by
0References
25Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 14, 2008 |
| Grant date | Oct 29, 2013 |
| Priority date | — |
| Expiry date | Jun 30, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to the identification of genetic markers patients with high risk B-precursor acute lymphoblastic leukemia (B-ALL) and associated methods and their relationship to therapeutic outcome. The present invention also relates to diagnostic, prognostic and related methods using these genetic markers, as well as kits which provide microchips and/or immunoreagents for performing analysis on leukemia patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.